Juan Vera - 24 Mar 2022 Form 4 Insider Report for Marker Therapeutics, Inc. (MRKR)

Role
Chief Scientific Officer & COO, Director
Signature
/s/ Michael Loiacono, Attorney-in-Fact
Issuer symbol
MRKR
Transactions as of
24 Mar 2022
Net transactions value
-$16,224
Form type
4
Filing time
28 Mar 2022, 21:04:44 UTC
Previous filing
22 Feb 2022
Next filing
19 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRKR Common Stock Award $0 +140,823 +5.5% $0.000000 2,705,310 24 Mar 2022 Direct F1
transaction MRKR Common Stock Tax liability $16,224 -33,465 -1.2% $0.4848 2,671,845 24 Mar 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit ("RSU") award.
F2 Represents shares withheld to satisfy tax obligations with respect to the vesting of the RSUs.